ACHC — Acadia Healthcare Company, Inc.

Is ACHC overbought or oversold? Here is the current MarketMoodz read.

Healthcare · Medical Care Facilities

Neutral As of October 3, 2026

Acadia Healthcare Company, Inc. (ACHC) currently reads Neutral on the MarketMoodz overbought/oversold meter, as of October 3, 2026. The Healthcare name (Medical Care Facilities) last closed at $28.06. The rating moved from Oversold to Neutral on October 3, 2026.

AI analysis

Acadia Healthcare Company, Inc. (ACHC) operates in a structurally growing behavioral‑health market with steady demand, a history of M&A‑driven expansion, and diversified payor exposure. Near‑term pressures include staffing and operating cost inflation, reimbursement sensitivity to payor and state policies, and a cautious capital markets backdrop that can slow acquisition financing. Key near‑term catalysts include successful integration of recent acquisitions, outpatient and telehealth growth, and improving payer contract terms. Main downside scenarios involve adverse reimbursement changes, elevated labor costs, or execution issues on integration that compress margins and free cash flow.

Key factors

  • Stable underlying demand for behavioral health and substance‑use disorder services supports recurring revenue streams for Acadia Healthcare Company, Inc. (ACHC).
  • History and strategy of growth through acquisitions provides a scalable roll‑up model and rapid capacity expansion in inpatient, outpatient and specialty behavioral services.
  • Diversified payer mix (commercial, Medicaid, Medicare) and wide geographic footprint reduce single‑market exposure but tie results to state Medicaid policies and reimbursement trends.
  • Ongoing secular drivers: increased recognition of mental‑health needs, insurance coverage expansion for behavioral care, and growing outpatient/telehealth utilization.
  • Cost pressure risk from labor (nursing/clinical staff) and facility operating costs that compress margins, especially during tight labor markets.
  • Macro and market sentiment: recent risk‑off tone and healthcare IPO cooling can constrain capital access/valuations for digital-health partners and slow M&A financing.
  • Regulatory and payor policy developments (Medicare Advantage benefit changes, negotiation pressures) can shift reimbursement dynamics and utilization patterns.

Risks

  • Reimbursement and payor pressure: shifts in Medicare Advantage plan structures, state Medicaid funding constraints, or payer renegotiations could reduce revenue or margins.
  • Policy/Regulatory risk: increased scrutiny, licensing changes, or state-level behavioral-health regulatory actions could raise compliance costs or constrain operations.
  • Labor and operating-cost inflation: sustained higher wages, staffing shortages or reliance on agency clinicians can materially increase operating expenses.
  • M&A execution risk: integration challenges, purchase price goodwill impairment, or slower-than-expected synergies from acquisitions.
  • Capital-market and financing risk: risk‑off environments reduce access to attractive financing for acquisitions or refinancing, raising cost of capital.
  • Competition and care migration: expansion of outpatient, telehealth, or competing specialist networks could erode inpatient pricing power and volumes.
  • Litigation and reputational risk: claims related to patient care, regulatory investigations or facility incidents could lead to fines, increased insurance costs or reputational damage.

See today's live rating, score and targets

Members see the live hourly rating for ACHC — the numeric AI score plus targets and entry zones — while this public page updates nightly.

Start the 14-day trial

This page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.